Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion
Thyme Care raised $125 million from investors, doubling its valuation to over $2 billion. This financing aims to address key gaps in cancer treatment.
SummaryAI generated
The cancer care startup Thyme Care announced the completion of a $125 million financing, with a valuation of over $2 billion. This round of financing was participated by several institutions, aiming to promote its technological development and market expansion in the field of cancer treatment.
Related eventsRELATED EVENTS
- 2026-09-04 22:32Nvidia acquired the open-source AI platform Hugging Face for approximately $12.93 billion.
- 2026-09-08 22:17French AI company Mistral received a $3 billion Series D financing led by Samsung, with a valuation of over 21 billion euros
- 2026-09-07 18:49①MIIT: To fully build a new generation of communication network that is comprehensive and advanced in performance; ②Huawei releases the high-performance chip Kirin 9050 Pro after six years; ③Aojie Technology: Alibaba reduced its holdings in the company by 5.2831 million shares from August 17 to September 7.
Key entitiesKEY ENTITIES
Thyme Care
SignalsSIGNALS
Keyword heat